OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Endocrinology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study	645
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study	365
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men	217
18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study	141
When selection becomes selection bias	115
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis	93
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock	89
Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps	79
Serum diiodotyrosine – a biomarker to differentiate destructive thyroiditis from Graves’ disease	78
Primary adrenal insufficiency in patients with CPOX gene mutations	70
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co	63
High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies	63
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy	60
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study	59
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?	54
Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study	49
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial	46
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment	43
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management	42
Transcriptional comparison of testicular adrenal rest tumors with fetal and adult tissues	41
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis	41
Genome-wide analysis of thyroid function in Australian adolescents highlights SERPINA7 and NCOA3	41
AMH as part of the diagnostic PCOS workup in large epidemiological studies	40
Metabolic health during a randomized controlled lifestyle intervention in women with PCOS	40
Bone strain index for fracture risk assessment in older men—the prospective STRAMBO study	39

Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial	39
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis	38
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors	37
Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves’ Orbitopathy	35
Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly	34
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis	33
Parathyroid hormone in situ measurement in patients with hyperparathyroidism: single-centre experience of 179 patients	33